BBOT
BridgeBio Oncology
BBOT
BBOT
31 hedge funds and large institutions have $171M invested in BridgeBio Oncology in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
2.44% less ownership
Funds ownership: 89.02% → 86.59% (-2.4%)
Holders
31
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.25M | |
| 2 | +$140K | |
| 3 | +$135K | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$32.5K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.48K |
Top Sellers
| 1 | -$949K | |
| 2 | -$534K | |
| 3 | -$57.1K | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$32.2K |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$24.6K |